News Archive | Page 17 of 23 | Lexaria Bioscience Corp.

News

New ViPova Products Introduced

Kelowna, BC / August 12, 2015 / Lexaria, Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company”) is pleased to announce a suite of new ViPovaTM products available for purchase immediately. The new products…

Lexaria Hires Investor Relations Firm

Kelowna, BC / August 11, 2015 / Lexaria, Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company”) announces it has hired Blue Ocean Advisors of San Diego, CA to assist in communicating its corporate,…

Laboratory Testing and Sales Distribution Update

Kelowna, BC / July 28, 2015 / Lexaria, Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company”) provides the following information to update both the status of the ongoing laboratory testing; and, of progress…

Lexaria Issues Shares as Per Management Contract

Kelowna, BC / July 22, 2015 / Lexaria, Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company”) announces it has issued 500,000 restricted common shares as per an existing management consulting contract, to Docherty…

Lexaria Lowers Prices

Kelowna, BC / July 14, 2015 / Lexaria, Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company”) is pleased to announce, effective immediately, new lower pricing for all its existing products. The new pricing…

Lexaria Announces Definitive Agreement

Kelowna, BC / June 26, 2015 / Lexaria, Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company”) announces it has signed the Definitive Agreement on the sale of its 49% interest in the Burlington…